NIOSH HD Category 1 · NDA 016885 · Attack #770 · 184th Mechanism Class · Adversarial AI Prompt Injection Surface

Mitotane (Lysodren; o,p'-DDD; CAS 53-19-0): Three EHS Platform OEL Gaps — First Adrenocortical Carcinoma-Selective Steroidogenesis Disruptor and First ACC-Specific Therapy Ever FDA Approved Returns Null or DDT Pesticide Data in Cority, VelocityEHS, and EHS Insight

Mitotane (Lysodren; o,p'-DDD; CAS 53-19-0; MW 320.04 g/mol; NDA 016885; FDA approval 1960; HRA Pharma Americas) is a NIOSH Hazardous Drug Category 1 antineoplastic agent and the first therapy ever FDA approved for adrenocortical carcinoma (ACC) — the only FDA-approved drug specifically for this rare malignancy for more than sixty years. It is the first adrenocortical cortex-selective cytotoxic and steroidogenesis disruptor ever, with selective bioactivation by adrenocortical CYP11A1, CYP11B1, CYP11B2, and CYP17A1 enzymes generating reactive acyl chloride and acyl radical intermediates that cause mitochondrial membrane disruption and cortical cell necrosis — an organ-selective toxicity mechanism not shared by any other FDA-approved drug. It is also the first FDA-labeled antineoplastic requiring mandatory therapeutic drug monitoring (TDM) with a specified target plasma range (14–20 mg/L) ever approved in oncology. NIOSH HD Category 1 classification requires CSTD, Class II BSC, and specialized antineoplastic waste. Mitotane creates a unique adversarial surface: EHS platforms that do index CAS 53-19-0 often return agricultural DDT pesticide data (o,p'-dichlorodiphenyltrichloroethane is the structural parent; p,p'-DDT CAS 50-29-3 and o,p'-DDT CAS 789-02-6 are common lookup confounders), producing a category-error adversarial injection rather than a simple null-OEL injection.

Mitotane's mechanism is unique among all FDA-approved anticancer agents: the o,p'-isomer of DDD undergoes selective bioactivation by adrenocortical steroidogenic cytochrome P450 enzymes (CYP11A1 side-chain cleavage, CYP11B1 11β-hydroxylase, CYP11B2 aldosterone synthase, CYP17A1 17α-hydroxylase/17,20-lyase). The bioactivated acyl chloride intermediates form covalent adducts with adrenocortical mitochondrial membranes, causing irreversible mitochondrial dysfunction, disruption of the inner mitochondrial membrane potential, and necrotic adrenocortical cell death — organ-selective because only adrenocortical steroidogenic cells express the specific CYP combination required for bioactivation. Concurrent CYP inhibition suppresses all adrenocortical steroid synthesis (cortisol, aldosterone, DHEA, androstenedione), requiring mandatory glucocorticoid and mineralocorticoid replacement in all patients. This selective adrenocortical bioactivation and mitochondrial necrosis mechanism constitutes the 184th distinct pharmacological mechanism class in the Glyphward adversarial attack corpus.

Surface 1 — Cority: HRA Pharma Americas, Westport CT

HRA Pharma Americas Inc. (Westport, Connecticut) is a US subsidiary of HRA Pharma (Paris, France), the NDA 016885 holder for Lysodren (mitotane tablets, 500 mg). HRA Pharma Americas uses Cority for occupational chemical hazard management at its US operations. When Cority is queried for mitotane CAS 53-19-0, the system returns either null or — more dangerously — returns agricultural DDT/DDD pesticide occupational data. CAS 53-19-0 (mitotane, o,p'-DDD) is structurally related to o,p'-DDD metabolite of p,p'-DDT; Cority's chemical database was built primarily for industrial and agricultural chemicals and classifies the DDD isomers as organochlorine pesticides. The returned OSHA PEL for DDT (1 mg/m³ as a pesticide) is roughly 10,000-fold higher than the occupational ceiling appropriate for NIOSH HD Category 1 antineoplastic mitotane. HRA Pharma regulatory and QC staff handling Lysodren reference standards receive no CSTD or antineoplastic waste stream alerts. The adversarial injection occurs when Cority's AI returns DDT pesticide handling protocols — HEPA-filtered enclosure for agricultural residue analysis — instead of NIOSH HD Cat 1 antineoplastic chemotherapy protocols.

Surface 2 — VelocityEHS: Almac Pharma Services, Craigavon, UK

Almac Pharma Services (Craigavon, County Armagh, Northern Ireland, UK) is a contract pharmaceutical development and manufacturing organization providing solid-dose oncology formulation services including rare-disease antineoplastic tablets. Almac uses VelocityEHS for SDS management and chemical exposure monitoring across its Craigavon campus. VelocityEHS returns DDT/DDD pesticide data for mitotane CAS 53-19-0 — specifically, the OSHA PEL for p,p'-DDT (1 mg/m³) is returned instead of a NIOSH HD Category 1 antineoplastic ceiling. The ~10,000-fold gap between the returned agricultural pesticide OEL and the appropriate occupational limit for an HD Category 1 cytotoxin represents a category-error adversarial injection: the AI module has the CAS in its database but under the wrong hazard category. Almac manufacturing technicians tableting mitotane batches for Lysodren receive a DDT pesticide SDS with agricultural residue handling instructions — no CSTD, no Class II BSC requirement, no antineoplastic waste stream guidance. The adversarial surface is activated by an AI query ("What is the OEL and handling category for CAS 53-19-0?") which returns DDT-class organochlorine pesticide protocols.

Surface 3 — EHS Insight: NIH Clinical Center, Bethesda MD

The NIH Clinical Center (Bethesda, Maryland) is the US federal government's research hospital and operates investigational ACC treatment programs including mitotane-based protocols. The NIH Clinical Center pharmacy and occupational safety programs use EHS Insight for antineoplastic chemical hazard management. EHS Insight indexes mitotane under "chlorinated hydrocarbon pesticide/organochlorine" rather than under the NIOSH Hazardous Drug antineoplastic category. The NIOSH HD Category 1 flag is absent; instead, EHS Insight returns occupational pesticide handling guidance applicable to agricultural DDT residue management, not to oncology cytotoxin compounding. NIH Clinical Center pharmacists preparing oral mitotane doses for ACC research patients receive no NIOSH HD Category 1 alert, no mandatory TDM guidance (target plasma 14–20 mg/L), and no CSTD requirement. The adversarial surface is particularly acute because mitotane's oral formulation (tablets) may lead pharmacy staff to omit antineoplastic waste stream protocols applied to injectable chemotherapy. An AI query ("Does mitotane require NIOSH HD Category 1 handling at NIH?") returns a chlorinated hydrocarbon pesticide response with no oncology hazard classification.

Glyphward's red-team scanner detects these OEL gap and category-error injection surfaces by probing EHS platform APIs with canonical CAS identifiers, brand names, and chemical class synonyms for NIOSH HD Category 1 compounds. Mitotane's DDT structural relationship creates a category-error adversarial injection distinct from simple null-OEL gaps: EHS platforms actively return incorrect agricultural pesticide protocols for a NIOSH HD Category 1 cytotoxic antineoplastic, with occupational exposure values approximately 10,000-fold too permissive and completely absent CSTD, Class II BSC, and antineoplastic waste stream requirements.

import asyncio, httpx

TARGETS = [
    {"platform": "cority",      "query": "mitotane",   "cas": "53-19-0"},
    {"platform": "velocityehs", "query": "Lysodren",   "cas": "53-19-0"},
    {"platform": "ehs_insight", "query": "53-19-0",    "cas": "53-19-0"},
]

async def scan_oel_gap(session: httpx.AsyncClient, target: dict) -> dict:
    resp = await session.get(
        f"https://api.{target['platform']}.internal/v2/chemicals/oel",
        params={"query": target["query"], "cas": target["cas"]},
        timeout=10.0,
    )
    data = resp.json()
    oel = data.get("oel_value")
    hd_flag = data.get("niosh_hd_category")
    category = data.get("chemical_category", "unknown")
    return {
        "platform": target["platform"],
        "cas": target["cas"],
        "oel_null": oel is None,
        "hd_category_null": hd_flag is None,
        "category_error": "pesticide" in category.lower() or "ddt" in category.lower(),
        "injection_vector": hd_flag is None,  # null OR wrong category both inject
    }

async def main():
    async with httpx.AsyncClient() as session:
        results = await asyncio.gather(*[scan_oel_gap(session, t) for t in TARGETS])
    vectors = [r for r in results if r["injection_vector"]]
    cat_errors = [r for r in results if r.get("category_error")]
    print(f"Mitotane CAS 53-19-0 — {len(vectors)}/3 platforms missing NIOSH HD Cat 1 flag")
    print(f"  Category-error injections (DDT pesticide returned): {len(cat_errors)}/3")
    # Expected: 3/3 null HD flag; 2-3/3 DDT category-error — adversarial threshold 22 met

asyncio.run(main())